Literature DB >> 1988448

Contributory effects of de novo transcription and premature transcript termination in the regulation of human epidermal growth factor receptor proto-oncogene RNA synthesis.

J D Haley1, M D Waterfield.   

Abstract

Overexpression of the epidermal growth factor (EGF) receptor (c-erbB) proto-oncogene is a frequent occurrence in human carcinoma and appears to accompany autocrine or paracrine transforming growth factor-alpha expression, which in model systems can result in activation of EGF receptor tyrosine kinase activity and phenotypic transformation. Here we have investigated the transcriptional regulation of the EGF receptor gene, by run-on transcription in isolated nuclei derived from epithelioid tumor lines. The level of transcription was measured at various points on the 100-kilobase pair EGF receptor gene locus, on either sense or antisense DNA strands. We find the level of sense strand transcription along exon 1 is 8-fold higher than transcription in exons 2-26. Primary EGF receptor transcripts appear to pause or terminate prematurely between exons 1 and 2. Termination was mapped to a sequenced region approximately 2 kilobase pairs 3' of exon 1, proximal to a previously reported DNase I hypersensitive site and an enhancer-like activity. Transcription in the CpG-rich region surrounding exon 1 is bidirectional, with antisense transcripts initiating in intron 1 and extending through the coding first exon. Activation of protein kinase C results in a 5-fold induction of EGF receptor transcription, accompanied by a slow release in the block RNA elongation between exon 2 and exon 26, showing that EGF receptor RNA synthesis may be altered by changes in de novo transcription and by a block to RNA elongation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988448

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  Transcriptional regulation of type I receptor tyrosine kinases in the mammary gland.

Authors:  N P Bates; H C Hurst
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-04       Impact factor: 2.673

2.  The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity.

Authors:  D Mukhopadhyay; B Knebelmann; H T Cohen; S Ananth; V P Sukhatme
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

Review 3.  Phenobarbital induction of cytochrome P-450 gene expression.

Authors:  D J Waxman; L Azaroff
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

4.  Noncanonical transcript forms in yeast and their regulation during environmental stress.

Authors:  Oh Kyu Yoon; Rachel B Brem
Journal:  RNA       Date:  2010-04-26       Impact factor: 4.942

Review 5.  Control of receptor sensitivity at the mRNA level.

Authors:  B J Morris
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

6.  Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts.

Authors:  F Pessler; P S Pendergrast; N Hernandez
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

7.  Transcription elongation in the human c-myc gene is governed by overall transcription initiation levels in Xenopus oocytes.

Authors:  C A Spencer; M A Kilvert
Journal:  Mol Cell Biol       Date:  1993-02       Impact factor: 4.272

8.  Chromatin structure of the EGFR gene suggests a role for intron 1 sequences in its regulation in breast cancer cells.

Authors:  S A Chrysogelos
Journal:  Nucleic Acids Res       Date:  1993-12-11       Impact factor: 16.971

9.  Expression of mRNA encoding the macrophage colony-stimulating factor receptor (c-fms) is controlled by a constitutive promoter and tissue-specific transcription elongation.

Authors:  X Yue; P Favot; T L Dunn; A I Cassady; D A Hume
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

10.  Functional analysis of a stable transcription arrest site in the first intron of the murine adenosine deaminase gene.

Authors:  S F Kash; J W Innis; A U Jackson; R E Kellems
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.